Every biologic drug, vaccine, and cell-based therapy begins its life in a dish which is why the nutrient solutions and cell populations that keep those cells alive have quietly become one of biotech's most strategically important supply categories. As biopharma pipelines swell with monoclonal antibodies, cell therapies, and treatments for rare and chronic diseases, demand for reliable,...
